DDR1 and ovarian carcinoma: Regarding cisplatin resistance in ovarian cancer, Deng and colleagues revealed miR-199a-3p as an upstream regulator of Discoidin Domain Receptor Tyrosine 1 (DDR1) (which confers the malignance and cisplatin resistance of ovarian cancer) that happens to be hypermethylated in ovarian cancer.